Katie Josephs

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2007

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive Metastatic Breast Cancer
May 2007 - May 2010
Breast Neoplasms
Lapatinib
Herceptin



